Effect of PCI on Quality of Life in Patients with Stable Coronary DiseaseWilliam S. Weintraub, William E. Boden, Christi Deaton et al.|New England Journal of Medicine|2008Cited by 732
Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary PatientsWilliam S. Weintraub, Paul G. Barnett, William E. Boden et al.|Circulation Cardiovascular Quality and Outcomes|2008Cited by 132
Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary InterventionSean C. Beinart, William S. Weintraub, Paul Kolm et al.|Journal of the American College of Cardiology|2005Cited by 122
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S. Weintraub, Koon Teo, Paul G. Barnett et al.|American Heart Journal|2006Cited by 26
Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trialPaul Kolm, William S. Weintraub, Yong Yuan et al.|Canadian Journal of Cardiology|2007Cited by 19